These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6369348)

  • 1. [Controlled study on the possible benefits of combination therapy with chlorimipramine and haloperidol inpatients with endogenous depression].
    Möller HJ; Kissling W; Herberger B; Kuss HJ
    Pharmacopsychiatry; 1984 Jan; 17(1):29-33. PubMed ID: 6369348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled trial on the possible advantages of a combined therapy with maprotiline and haloperidol in endogenous depression.
    Möller HJ; Kissling W; Herberger B; Binz U; Wendt G; Spahn H
    Pharmacopsychiatry; 1986 Sep; 19(5):362-4. PubMed ID: 3534899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial application of clonidine tests during antidepressive treatment with chlorimipramine.
    Möller HJ; Kissling W; Bottermann P
    Pharmacopsychiatry; 1984 Nov; 17(6):184-7. PubMed ID: 6514781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study.
    Wolfersdorf M; Wendt G; Binz U; Steiner B; Hole G
    Pharmacopsychiatry; 1988 Jul; 21(4):203-7. PubMed ID: 3060885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of depression with L-5-hydroxytryptophan combined with chlorimipramine, a double-blind study.
    Nardini M; De Stefano R; Iannuccelli M; Borghesi R; Battistini N
    Int J Clin Pharmacol Res; 1983; 3(4):239-50. PubMed ID: 6381336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of Hydiphen in the treatment of endogenous depression].
    Nowakowska C; Chłopocka-Woźniak M; Strzyzewski W
    Psychiatr Pol; 1989; 23(1):10-7. PubMed ID: 2682710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvoxamine and chlorimipramine in endogenous depression.
    De Wilde JE; Doogan DP
    J Affect Disord; 1982 Sep; 4(3):249-59. PubMed ID: 6215443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
    Ehmann TS; Delva NJ; Beninger RJ
    J Clin Psychopharmacol; 1987 Jun; 7(3):173-5. PubMed ID: 3298328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined chlorimipramine and maprotiline therapy in therapy-resistant depressions].
    Soucek K
    Act Nerv Super (Praha); 1982 May; 24(2):88-9. PubMed ID: 7102229
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of clomipramine and doxepin in neurotic depression.
    Kornhaber A; Horwitz IM
    J Clin Psychiatry; 1984 Aug; 45(8):337-41. PubMed ID: 6378895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary MHPG is not a good predictor of antidepressive drug response.
    Puzyński S; Rode A; Bidziński A; Mrozek S; Załuska M
    Pol J Pharmacol Pharm; 1984; 36(4):329-35. PubMed ID: 6527968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with maprotilin and maprotilin/clomipramine infusions in resistant depression.
    Zapletálek M; Zbytovský J; Kudrnová K
    Act Nerv Super (Praha); 1982 May; 24(2):73-6. PubMed ID: 7102227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of controlled studies comparing mianserin and clomipramine (author's transl)].
    de Buck RP
    Encephale; 1981; 7(4 Suppl):455-72. PubMed ID: 7032887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A control study of intravenous versus oral clomipramine in major depression].
    Zhao J
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Feb; 25(1):9-12, 60. PubMed ID: 1591963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double blind test with mianserin versus chlorimipramine.
    Rapisarda V; Bongiorno G
    Adv Biochem Psychopharmacol; 1982; 32():141-9. PubMed ID: 6283807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use.
    Wolfersdorf M; Barg T; König F; Leibfarth M; Grünewald I
    Pharmacopsychiatry; 1995 Mar; 28(2):56-60. PubMed ID: 7624387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of live and videotape ratings: clomipramine and haloperidol in autism.
    Sanchez LE; Adams PB; Uysal S; Hallin A; Campbell M; Small AM
    Psychopharmacol Bull; 1995; 31(2):371-8. PubMed ID: 7491394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS; Zimmerman RL
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.